LabCorp VistaSeq Hereditary Cancer Panel

Laboratory Corporation of America has launched 10 new panels to test for risk of specific hereditary cancer syndromes. The number of cancer genes that can be assessed has been increased to 59. The VistaSeq Hereditary Cancer Panel assesses genetic mutations associated with common hereditary cancers, such as breast, ovarian, melanoma, pancreatic, colorectal, endometrial, gastric, and prostate cancers.